G04CA03 - Terazosin |
Probably not porphyrinogenic |
PNP |
Rationale
No data pointing to CYP-interaction. Two references authorised / use with care.
Chemical description
Used in hypertrophic prostatic disease, 2-5 mg/d. Quinazoline derivative with selective effect on alpha-1-receptors in the bladder, giving rise to relaxation. Metabolized in the liver by hydrolysis and demethylation. No data pointing to CYP-interaction.
IPNet drug reports
Uneventful use reported in 3 patients with acute porphyria.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | French List
Centre Français des Porphyries
|
|
| 2. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames
Hytrin · Terazosine 
Hytrin · Terazosab · Terazosine 
Dysalfa · Hytrine · Terazosine 
Alfaprost · Deflox · Magnurol · Mayul · Sutif · Terazosina · Zayasel 
Setegis 
Prostatil · Terafluss · Teraprost · Terazosina · Unoprost · Urodie · Uroflus 
Hytrin 
Benph · Hytrin · Terazosin 
Sinalfa 
Hytrinex · Sinalfa · Terablock · Terazosin 
Heitrin · Hytrin · Sinalfa · Terablock · Terazosin 
Hytrin · Kornam 
Hytrin · Terazosina 
Hytrin · Terazosin 
Hytrin · Terasin 
Terazosin 
Hytrin · Terazosab 
Terazosin 
Kornam 
Kornam 
Kornam 
Terazosine 
Terazosina 
Terazosin